About 65% of melanoma patients do not respond to immunotherapy. New work by the team of Prof. Max Mazzone (VIB-KU Leuven ...

A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for ...

A major step forward has been made in predicting how well melanoma patients would respond to treatment, thanks to ...

Portable multiphoton microscopy system uses femtosecond laser pulses to create pathology-quality diagnostic images ...

The Brain Prize 2025 went to neuro-oncologists Michelle Monje and Frank Winkler for pioneering the field of cancer n.

Scientists are finding microplastics everywhere from brain tissue to arteries and warning of the health risks posed by their ...

RAD52 has already shown promise as a drug target. Inhibitors of the protein can selectively kill cancerous cells while ...

A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and protects replicating DNA in dividing cells. This new structural and ...

A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and ...

A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing ...

Discover what every stage of breast cancer means for treatment options and recovery, with expert insights to help navigate a ...

Dr. James Lim, associate professor of pediatrics at UBC’s faculty of medicine, observes pediatric cancer cells grown in a ...